Health Outcomes around Pregnancy and Exposure to HIV/Antiretrovirals (HOPE) study protocol: a prospective observational cohort study of reproductive-aged women living with HIV
Deborah Kacanek,Lynn M Yee,Tzy-Jyun Yao,Jessica Lee,Ellen G Chadwick,Paige L Williams,Emily A Barr,Claire A Berman,Mariam Davtyan,Alex DiPerna,Amanda Flores,Jennifer Green,Lisa B Haddad,Laurie Hyzy,Denise L Jacobson,Tamarra James-Todd,Jennifer Jao,Anisa Khadraoui,Kathleen M Malee,Anna-Barbara Moscicki,Kunjal Patel,Lisa-Gaye Robinson,Liz Salomon,Kimbrae Sanders,Suzanne Siminski,Renee A Smith,Tracy Wolbach,Kathleen M Powis,Health Outcomes around Pregnancy and Exposure to HIV/Antiretrovirals (HOPE) Study,Health Outcomes in Pregnancy and Exposure to HIV/Antiretrovirals (HOPE) Study,Lela Lartey,Kathleen Malee,Mary Paul,Alejandra Martinez,Lynnette Harris,Murli Purswani,Martha Cavallo,Mahoobullah Mirza Baig,Alma Villegas-Schwalenberg,Kierra Archer,Alan Bernegger,Patricia Garvie,Katherine Knapp,Chloe Burkhead,Gheri Terry,Megan Wilkins,Margarita Silio,Dornese Jones,Medea Gabriel,Patricia Sirois,Cecelia Hutto,Paige Hickman,Dan Marullo,Elizabeth McFarland,Carrie Chambers,Robin McEvoy,Mobeen Rathore,Saniyyah Mahmoudi,Staci Routman,Gwendolyn Scott,Lorena Bracho,Anai Cuadra,Zoe M Rodriguez,Lizmarie Torres,Nydia Scalley,Toniette Frederick,Cristina Hernandez,Guadalupe Morales Avendano
DOI: https://doi.org/10.1136/bmjopen-2024-084835
IF: 3.006
2024-07-05
BMJ Open
Abstract:Introduction: Over 265 000 women are living with HIV in the USA, but limited research has investigated the physical, mental and behavioural health outcomes among women living with HIV of reproductive age. Health status during the reproductive years before, during and after pregnancy affects pregnancy outcomes and long-term health. Understanding health outcomes among women living with HIV of reproductive age is of substantial public health importance, regardless of whether they experience pregnancy. The Health Outcomes around Pregnancy and Exposure to HIV/Antiretrovirals (HOPE) study is a prospective observational cohort study designed to investigate physical and mental health outcomes of young women living with HIV as they age, including HIV disease course, engagement in care, reproductive health and choices and cardiometabolic health. We describe the HOPE study design, and characteristics of the first 437 participants enrolled as of 1 January 2024. Methods and analysis: The HOPE study seeks to enrol and follow 1630 women living with HIV of reproductive age, including those with perinatally-acquired HIV, at 12 clinical sites across 9 US states and Puerto Rico. HOPE studies multilevel dynamic determinants influencing physical, mental and social well-being and behaviours of women living with HIV across the reproductive life course (preconception, pregnancy, post partum, not or never-pregnant), informed by the socioecological model. Key research areas include the clinical course of HIV, relationship of HIV and antiretroviral medications to reproductive health, pregnancy outcomes and comorbidities and the influence of racism and social determinants of health. HOPE began enrolling in April 2022. Ethics and dissemination: The HOPE study received approval from the Harvard Longwood Campus Institutional Review Board, the single institutional review board of record for all HOPE sites. Results will be disseminated through conference presentations, peer-reviewed journals and lay summaries.